| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.72B | 8.69B | 6.18B | 5.38B | 30.13B | 35.57B |
| Gross Profit | 3.57B | 4.61B | 2.93B | 453.00M | 13.39B | 14.72B |
| EBITDA | 1.05B | 1.85B | 364.00M | -1.92B | 17.96B | 557.00M |
| Net Income | 912.00M | 1.59B | 171.00M | -1.85B | 11.55B | 7.00M |
Balance Sheet | ||||||
| Total Assets | 14.10B | 15.63B | 15.86B | 17.45B | 31.31B | 33.57B |
| Cash, Cash Equivalents and Short-Term Investments | 11.63B | 12.76B | 13.47B | 11.73B | 29.66B | 22.23B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 50.00M | 3.17B |
| Total Liabilities | 3.33B | 3.89B | 2.70B | 2.27B | 9.40B | 21.12B |
| Stockholders Equity | 10.60B | 11.57B | 13.02B | 15.02B | 21.44B | 9.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.45B | 478.00M | -7.71B | 3.48B | 7.35B |
| Operating Cash Flow | 0.00 | 2.54B | 1.23B | -7.46B | 3.67B | 7.82B |
| Investing Cash Flow | 0.00 | -1.09B | 346.00M | 8.16B | -5.15B | 317.00M |
| Financing Cash Flow | 0.00 | -3.18B | -2.27B | -4.75B | -1.39B | 955.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥67.17B | 11.62 | 17.21% | 4.27% | 13.39% | 22.06% | |
72 Outperform | ¥2.03T | 5.92 | 20.02% | 2.63% | 31.37% | 148.24% | |
72 Outperform | ¥11.50B | 14.30 | ― | ― | 38.93% | 191.23% | |
71 Outperform | ¥25.31B | 14.35 | ― | 18.63% | 40.56% | 840.38% | |
70 Outperform | ¥39.44B | 6.17 | 6.18% | 4.42% | 30.88% | 193.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥120.31B | 30.49 | 5.11% | 5.07% | -26.93% | -29.39% |